NCT03517358已完成3 期
Virological Suppression in HIV Positive Patients Involved in a Novel, Standardized Adherence Protocol
适应症
干预措施
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- Percentage of virological suppression
研究概览
简要总结
This study will look at virologically suppression of patients with HIV who receive pharmacist or case management care.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Patients with a baseline viral load > 200 copies/ml
- •Patients who agree to program enrollment
- •Patients ≥ 18 years of age
排除标准
- •Pregnant women
- •Adults unable to consent
- •Prisoners
研究组 & 干预措施
Pharmacy
Active Comparator
service of care: pharmacy
干预措施: Service of care (Other)
Case management
Active Comparator
service of care: case management
干预措施: Service of care (Other)
结局指标
主要结局
Percentage of virological suppression
时间窗: 6 months
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
HIV Expression in Patients With Low Viral Load on Highly Active Antiretroviral Therapy (HAART)HIV InfectionsNCT00043641National Institute of Allergy and Infectious Diseases (NIAID)73
招募中
2 期
Early Metabolic Effects of Antiretroviral Drugs in Healthy volUnteers: a Phase 2 Randomized StudyWeight GainHealthy VolunteerMetabolic EffectsIntegrase Strand Transfer InhibitorsNCT05652478National Institute of Allergy and Infectious Diseases (NIAID)120
已完成
2 期
A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected PatientsHIV InfectionsNCT00001084National Institute of Allergy and Infectious Diseases (NIAID)500
终止
1 期
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With HyperlipidemiaHyperlipidemiaHIV InfectionsNCT00663234International Maternal Pediatric Adolescent AIDS Clinical Trials Group28
已完成
1 期
Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With TuberculosisHIV InfectionsTuberculosisNCT00004736National Institute of Allergy and Infectious Diseases (NIAID)44